(Total Views: 121)
Posted On: 10/04/2021 1:45:51 PM
Post# of 22

$XNCR News Article - Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies https://marketwirenews.com/news-releases/xenc...94206.html


My Twitter: WhyteStocks